The names on this page are hidden. Create a free account to reveal 5 records a month, or get Private Credit Intelligence at $249 a month for every name. Every figure, date and source on this page is public either way.

Borrower

T••••••• T••••••••• L••••••

Drug Discovery & Developmentgroup grade Aon a schedule nowsponsor S•••••••• P••••••• carried
Principal held
at least $18.8M
sum of BDC pieces, a lower bound
Fair value
$18.3M
98c on cost, debt pieces
Unfunded
n/a
commitments not yet drawn
BDC lenders
1
1 on the latest quarter
Facilities
1
0 equity pieces beside them
Next maturity
Oct 1, 2029
no dated debt inside 24 months
On the tape since
Mar 31, 2026
latest Jun 30, 2026
Events
1
dated, non-routine
Capital structure as the BDCs see it
latest quarter end Jun 30, 2026
FacilityHeldOn costPricingMaturityBDCs
first lien term loan first lienat least $18.8M98cS+290 bpOct 1, 20291
Lenders
every BDC piece at the latest quarter end
BDCInstrumentPrincipalFair valueRate
H••••••• C••••••• I•••term loan first lien
S••••• S••••••, O•••••• 2029, P•••• + 2.90%, F•••• rate 10.40%, 6.65% E••• Fee
$18.8M$18.3M
98c
S+290 bp
Through time
the borrower's pieces summed across BDCs, every quarter end
Quarter endBDCsPrincipal heldFair valueOn costPIK pieces
Jun 30, 20261$18.8M$18.3M98c0
Mar 31, 20261$18.8M$18.6M100c0
What changed
Every change including routine ones
Identity
Group key
T••••••• T•••••••••derivedthe codename stem after legal suffixes and deal words
Spellings
1 across 1 BDCderived
Industry
Drug Discovery & Developmentreportedas one filer wrote it